TRCT
ALHC icon

Tower Research Capital (TRC)’s Alignment Healthcare ALHC Stock Holding History

Tower Research Capital (TRC)’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
5,500
-12,116
-69% -$233K ﹤0.01% 1992
2026
Q1 		$310K Buy
17,616
+7,298
+71% +$147K 0.01% 1284
2025
Q4 		$204K Buy
10,318
+4,512
+78% +$81.1K ﹤0.01% 1423
2025
Q3 		$101K Sell
5,806
-13,873
-70% -$206K ﹤0.01% 1981
2025
Q2 		$276K Buy
19,679
+18,784
+2,099% +$302K 0.01% 1500
2025
Q1 		$16.7K Sell
895
-9,676
-92% -$144K ﹤0.01% 3149
2024
Q4 		$119K Buy
10,571
+6,286
+147% +$73.5K ﹤0.01% 2060
2024
Q3 		$50.6K Sell
4,285
-6,239
-59% -$59K ﹤0.01% 2715
2024
Q2 		$82.3K Buy
10,524
+10,040
+2,074% +$65.5K ﹤0.01% 2723
2024
Q1 		$2.4K Sell
484
-18,616
-97% -$119K ﹤0.01% 5045
2023
Q4 		$164K Buy
19,100
+14,821
+346% +$108K ﹤0.01% 2255
2023
Q3 		$29.7K Sell
4,279
-3,304
-44% -$19.9K ﹤0.01% 3035
2023
Q2 		$43.6K Buy
7,583
+4,652
+159% +$30.1K ﹤0.01% 2690
2023
Q1 		$19K Buy
2,931
+2,089
+248% +$19.9K ﹤0.01% 3465
2022
Q4 		$10K Sell
842
-16,926
-95% -$206K ﹤0.01% 3943
2022
Q3 		$210K Buy
17,768
+14,808
+500% +$216K ﹤0.01% 1882
2022
Q2 		$34K Buy
2,960
+1,784
+152% +$18.8K ﹤0.01% 3236
2022
Q1 		$13K Sell
1,176
-5,315
-82% -$47.8K ﹤0.01% 3952
2021
Q4 		$91K Buy
6,491
+2,306
+55% +$40.4K ﹤0.01% 2286
2021
Q3 		$67K Buy
4,185
+3,864
+1,204% +$74.6K ﹤0.01% 2720
2021
Q2 		$8K Sell
321
-40
-11% -$973 ﹤0.01% 4474
2021
Q1 		$8K Buy
+361
New +$7.06K ﹤0.01% 4458

Other funds holding ALHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tower Research Capital (TRC)'s ALHC Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Alignment Healthcare (ALHC) stake by 69% in Q2 2026, selling an estimated $233K and leaving 5,500 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

Tower Research Capital (TRC) first reported a position in ALHC in Q1 2021 and has held it in 22 quarters since. The position peaked at $310K in Q1 2026. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Tower Research Capital (TRC) held 5,500 shares of Alignment Healthcare worth $131K as of Q2 2026.
  • Tower Research Capital (TRC) sold 12,116 Alignment Healthcare shares in Q2 2026, an estimated $233K.
  • Alignment Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1992 holding.
  • Tower Research Capital (TRC) first reported a position in Alignment Healthcare in Q1 2021 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Alignment Healthcare position peaked at $310K in Q1 2026.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.